NASDAQ: AVGR - Avinger, Inc.

Доходность за полгода: -44.54%
Сектор: Healthcare

График акции Avinger, Inc.


О компании

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

подробнее
The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.

EBITDA -0.0185
EV/EBITDA -0.6146
IPO date 2015-01-30
ISIN US0537348858
Industry Health Care Equipment & Supplies
P/BV 1.23
P/S 0.9276
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.0091
Сайт https://avinger.com
Цена ао 2.95
Число акций ао 0.000786 млрд
Изменение цены за день: -24.61% (1.28)
Изменение цены за неделю: +99.96% (0.4826)
Изменение цены за месяц: +15.96% (0.8322)
Изменение цены за 3 месяца: -2% (0.9847)
Изменение цены за полгода: -44.54% (1.74)
Изменение цены за год: -64.39% (2.71)
Изменение цены за 3 года: +82.08% (0.53)
Изменение цены за 5 лет: -34.35% (1.47)
Изменение цены за 10 лет: 0% (0.965)
Изменение цены с начала года: +52.96% (0.6309)

Недооценка

Название Значение Оценка
P/S 0.2825 10
P/BV -0.3485 0
P/E 0 0
EV/EBITDA -0.8056 0
Итого: 5

Эффективность

Название Значение Оценка
ROA, % -133.04 0
ROE, % 295.39 10
Итого: 3.33

Дивиденды

Название Значение Оценка
Div yield, % 0 0
DSI 0 0
Итого: 0

Долг

Название Значение Оценка
Debt/EBITDA -1.01 10
Итого: 9.6

Импульс роста

Название Значение Оценка
Доходность Revenue, % -15.91 0
Доходность Ebitda, % -15.74 0
Доходность EPS, % -57.29 0
Итого: 0

Институционалы Объем Доля, %
Vanguard Group Inc 23802 1.5
Blackrock Inc. 5607 0.35
Tower Research Capital LLC (TRC) 2026 0.13
UBS Group AG 908 0.06
City State Bank 225 0.01
Highmark Wealth Management LLC 127 0.01
Qube Research & Technologies Ltd 92 0.01
Citigroup Inc. 37 0
Osaic Holdings Inc 34 0
Wells Fargo & Company 11 0



Руководитель Должность Оплата Год рождения
Mr. Jeffrey M. Soinski CEO & Director 616.79k 1962 (63 года)
Mr. Nabeel P. Subainati Vice President of Finance 347.58k 1984 (41 год)
Mr. Himanshu N. Patel Chief Technology Officer 430.08k 1960 (65 лет)
Mr. Keith Schaefer Chief Operating Officer N/A
Mr. Corey Gibbs Vice President of Sales N/A
Dr. Jaafer Golzar FACC, M.D. Chief Medical Officer N/A
Mr. Philip R. Preuss Chief Marketing Officer & VP of Business Operations N/A 1978 (47 лет)

Адрес: United States, Redwood City. CA, 400 Chesapeake Drive - открыть в Google картах, открыть Яндекс картах
Сайт: https://avinger.com